Risk Stratification of Myelodysplastic Syndromes
Hematologist-oncologists discuss the risk stratification of patients with myelodysplastic syndromes and how patient risk status determines prognosis.
Source: onclive.com
Stay updated with breaking news from Ipss R. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hematologist-oncologists discuss the risk stratification of patients with myelodysplastic syndromes and how patient risk status determines prognosis.
A panel of expert hematologists give an overview of myelodysplastic syndrome, focusing on diagnosis, classification, and treatment practices.